Ethinylestradiol liposome preparation and its effects on ovariectomized rats’ osteoporosis

References

• Ali MH, Kirby DJ, Mohammed AR, Perrie Y. 2010. Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilizing agent. J Pharm Pharmacol 62:1–10.
   PubMedGoogle Scholar
• Barenholz Y. 2001. Liposome application: problems and prospects. Current Opinion in Colloid & Interface Science 6:66–77.
   Web of Science ®Google Scholar
• Black DM, Eastell R, Boonen S, Bucci-Rechtweg C, Mesenbrink P. 2009. Time to onset of anti-fracture efficacy and persistence of effect of zoledronic acid 5 mg in women with osteoporosis or recent hip fracture. Bone 44: S234–S252
   Google Scholar
• Boivin G, Vedi S, Purdie DW, Compston JE, Meunier PJ. 2005. Influence of estrogen therapy at conventional and high doses on the degree of mineralization of iliac bone tissue: a quantitative microradiographic analysis in postmenopausal women. Bone 36: 562–567.
   PubMed Web of Science ®Google Scholar
• Bonewald LF, Johnson ML. 2008. Osteocytes, mechanosensing and Wnt signaling. Bone 42: 606–615.
   PubMed Web of Science ®Google Scholar
• Breitman PL, Fonseca D, Cheung AM, Ward WE. 2003. Isoflavones with supplemental calcium provide greater protection against the loss of bone mass and strength after ovariectomy compared to isoflavones alone. Bone 33: 597–605.
   PubMed Web of Science ®Google Scholar
• Cederroth CR, Nef S. 2009. Soy, Phytoestrogens and metabolism: A review. Mol Cell Endocrinol 304: 30–42.
   PubMed Web of Science ®Google Scholar
• Cuzick J. 2008. Hormone replacement therapy,and the risk of breast cancer. European J Cancer 44: 2344–2349.
   PubMed Web of Science ®Google Scholar
• De Laet C, Kanis JA, Oden A, Johanson H, Johnell O, Delmas P. 2005. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16: 1330–1338.
   PubMed Web of Science ®Google Scholar
• Demir B, Haberal A, Geyik P, Baskan B, Ozturkoglu E, Karacay O, Deveci S. 2008. Identification of the risk factors for osteoporosis among postmenopausal women. Maturitas 60:253–256.
   PubMed Web of Science ®Google Scholar
• Eskridge SL, Morton DJ. 2010. Estrogen Therapy and Bone Mineral Density in African-American and Caucasian Women. Am J Epidemiol 171: 808–816.
   PubMed Web of Science ®Google Scholar
• Feng YJ, Wang C, Liu JF, Zhang ZH. 2010. Electrochemical degradation of 17-alpha-ethinylestradiol (EE2) and estrogenic activity changes. J Environ Monit 12: 404–408.
   PubMed Web of Science ®Google Scholar
• Fonseca D, Ward WE. 2004. Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. Bone 35: 489–497.
   PubMed Web of Science ®Google Scholar
• Garg M, Mishra D, Agashe H, Jain NK. 2006. Ethinylestradiol-loaded ultraflexible liposomes: pharmacokinetics and pharmacodynamics. J Pharm Pharmacol 58, 459–468.
   PubMed Web of Science ®Google Scholar
• Gobbi S, Cavalli A, Negri M, Schewe KE, Belluti F, Piazzi L, Hartmann RW, Recanatini M, Bisi A. 2007. Imidazolylmethylbenzophenones as highly potent aromatase inhibitors. J Med Chem 50:3420–3422.
   PubMed Web of Science ®Google Scholar
• Gregoriadis G, Davis C. 1979. Stability of liposomes in vivo and in vitro is promoted by their cholesterol content in the presence of blood cells. Biochim Biophys Res Commun 90: 1287–1293.
   PubMedGoogle Scholar
• Hagino H, Nishizawa Y, Sone T, Morii H, Taketani Y, Nakamura T, Itabashi A, Mizunuma H, Ohashi Y, Shiraki M, Minamide T, Matsumoto T. 2009. A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis. Bone 44: 1078–1084.
   PubMed Web of Science ®Google Scholar
• Hathout RM, Mansour S, Mortada ND, Guinedi AS. 2007. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech 8(1):E1–E12.
   PubMedGoogle Scholar
• Hengst V, Oussoren C, Kissel T, Storm G. 2007. Bone targeting potential of bisphosphonate-targeted liposomes Preparation, characterization and hydroxyapatite binding in vitro. Int J Pharm 331: 224–227.
   PubMed Web of Science ®Google Scholar
• Hughes GA. 2005. Nanostructure-mediated drug delivery. Nanomedicine: Nanotechnol Biol Med 1: 22–30.
   PubMed Web of Science ®Google Scholar
• Kateb NE, Cynober L, Chaumeil JC, Dumortier G. 2008. L-cysteine encapsulation in liposomes: Effect of phospholipids nature on entrapment efficiency and stability. J Microencapsulation 25(6): 399–413.
   PubMed Web of Science ®Google Scholar
• Kirby C, Gregoriadis G. 1980. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J 186: 591–598.
   PubMed Web of Science ®Google Scholar
• Kita M, Kondo M, Koyama T, Yamada K, Matsumoto T, Lee K, Woo J, Uemura D. 2004. Symbioimine exhibiting inhibitory effect of osteoclast differentiation, from the symbiotic marine dinoflagellate symbiodinium sp. J Am Chem Soc 126: 4794–4795.
   PubMed Web of Science ®Google Scholar
• Lindenfeld EA, Langer RD. 2002. Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial. Obstet Gynecol 100: 853–863.
   PubMed Web of Science ®Google Scholar
• Makras P, Hamdy NAT, Zwinderman AH, Ballieux BEPB, Papapoulos SE. 2009. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis. Bone 44: 766–771.
   PubMed Web of Science ®Google Scholar
• Mamot C, Drummond DC, Hong K, Kirpotin D, Park JW. 2003. Liposome-based approaches to overcome anticancer drug resistance. Drug Resist Updat 6:271–279.
   PubMed Web of Science ®Google Scholar
• Mohammed AR, Weston N, Coombes AGA, Fitzgerald M, Perrie Y. 2004. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharmaceutics 285: 23–34.
   PubMed Web of Science ®Google Scholar
• Nounou MM, EL-Khordagui LK, Khalafalla NA, Khalil SA. 2006. In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels. Acta Pharm 56: 311–324.
   PubMedGoogle Scholar
• Otsuka M, Oshinbe A, LeGeros RZ, Tokudome Y, Ito A, Otsuka K, Higuchi WI. 2008. Efficacy of the injectable calcium phosphate ceramics suspensions containing magnesium, zinc and fluoride on the bone mineral deficiency in ovariectomized rats. J Pharm Sci 97: 421–432.
   PubMed Web of Science ®Google Scholar
• Pasco JA, Henry MJ, Nicholson GC, Brennan SL, Kotowicz MA. 2009. Behavioural and physical characteristics associated with vitamin D status in women. Bone 44: 1085–1091.
   PubMed Web of Science ®Google Scholar
• Peng KW, Wang HL, Qin ZH, Wijewickrama GT, Lu ML, Wang ZC, Bolton JL, Thatcher GRJ. 2009. Selective Estrogen Receptor Modulator Delivery of Quinone Warheads to DNA Triggering Apoptosis in Breast Cancer Cells. ACS Chem. Biol. 4: 1039–1049
   PubMed Web of Science ®Google Scholar
• Peng KW, Chang MS, Wang YT, Wang ZC, Qin ZH, Bolton JL, Thatcher GRJ. 2010. Unexpected Hormonal Activity of a Catechol Equine Estrogen Metabolite Reveals Reversible Glutathione Conjugation. Chem. Res. Toxicol. 23: 1374–1383
   PubMed Web of Science ®Google Scholar
• Poiana C, Carsote M, Neacsu E, Barbu C, Gruia A, Samoila R, Ene C. 2009. Vitamin D levels and bone mineral density in 174 postmenopausal. Bone 44: S398.
   Web of Science ®Google Scholar
• Quadir MA, Radowski MR, Kratz F, Licha K, Hauff P, Haag R. 2008. Dendritic multishell architectures for drug and dye transport. J Control Release 132: 289–294.
   PubMed Web of Science ®Google Scholar
• Raudaskoski T, Tapanainen J, Tomás E, Luotola H, Pekonen F, Ronni-Sivula H, Timonen H, Riphagen F, Laatikainen T. 2002. Intrauterine 10μg and 20μg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response. BJOG: An Int J Obstet Gynaecol 109: 136–144.
   PubMed Web of Science ®Google Scholar
• Renoir J, Stella B, Ameller T, Connault E, Opolon P, Marsaud V. 2006. Improved anti-tumoral capacity of mixed and pure anti-oestrogens in breast cancer cell xenografts after their administration by entrapment in colloidal nanosystems. J Steroid Biochem Mol Biol 102: 114–127.
   PubMed Web of Science ®Google Scholar
• Riera-Espinoza GS, Ramos J, Belzares E. 2009. Vitamin D deficiency in postmenopausal women with osteoporosis in Venezuela. Bone 44: S359.
   Web of Science ®Google Scholar
• Rizzoli R, Felsenberg D, Laroche M, Seeman E, Krieg M, Frieling I, Thomas T, Delmas P. 2009. Strontium ranelate has a more positive influence than alendronate on distal tibia cortical and trabecular bone microstructure in women with postmenopausal osteoporosis. Bone 44: S211–S226.
   Google Scholar
• Schindeler A, Little DG. 2007. Bisphosphonate action: Revelations and deceptions from in vitro studies. J Pharm Sci 96: 1872–1878.
   PubMed Web of Science ®Google Scholar
• Schmidt JM, Tremblay GB, Plastina MA, Ma F, Bhal S, Feher M, Dunn-Dufault R., Redden PR. 2005. In vitro evaluation of the anti-estrogenic activity of hydroxyl substituted diphenylnaphthyl alkene ligands for the estrogen receptor. Bioorg Med Chem 13: 1819–1828.
   PubMed Web of Science ®Google Scholar
• Setchell KDR, Brzezinski A, Brown NM, Desai PB, Melhem M, Meredith T, Zimmer-Nechimias L, Wolfe B, Cohen Y, Blatt Y. 2005. Pharmacokinetics of a slow-release formulation of soybean isoflavones in healthy postmenopausal women. J Agric Food Chem 53:1938–1944.
   PubMed Web of Science ®Google Scholar
• Shargorodsky M, Boaz M, Luckish A, Matas Z, Gavish D, Mashavi M. 2009. Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women. Atherosclerosis 204: 608–611.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Nagase Y, Iga K, Kawase M, Oka M, Yanai S, Matsumoto Y, Nakagawa S, Fukuda T, Adachi H, Higo N, Ogawa Y. 2002. Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH(1-34). J Pharm Sci 91: 350–361.
   PubMed Web of Science ®Google Scholar
• Tabasum Parvez MD, 2004. Postmenopausal osteoporosis. JK-Practitioner 11(4): 281–283
   Google Scholar
• Timmer MHM, Samson MM, Monninkhof EM, Ree BD, Verhaar HJJ. 2009. Predicting osteoporosis in patients with a low-energy fracture. Arch Gerontol Geriatr 49: e32–e35
   PubMed Web of Science ®Google Scholar
• Tyler CR, Filby AL, Bickley LK, Cumming RI, Gibson R, Labadie P, Katsu Y, Liney KE, Shears JA, Silva-Castro V, Urushitani H, Lange A, Winter MJ, Iguchi T, Hill EM. 2009. Environmental health impacts of equine estrogens derived from hormone replacement therapy. Environ Sci Technol 43: 3897–3904.
   PubMed Web of Science ®Google Scholar
• Uusi-Rasi K, Rauhio A, Kannus P, Pasanen M, Kukkonen-Harjula K, Fogelholm M, Sievänen H. 2010. Three-month weight reduction does not compromise bone strength in obese premenopausal women. Bone 46:1286–1293.
   PubMed Web of Science ®Google Scholar
• Vangala A, Kirby D, Rosenkrands I, Agger EM, Andersen P, Perrie Y. 2006. A comparative study of cationic liposome and niosome-based adjuvent systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice. J Pharm Pharmacol 58:787–799.
   PubMed Web of Science ®Google Scholar
• Widler L, Jaeggi KA, Glatt M, Müller K, Bachmann R, Bisping M, Born A, Cortesi R, Guiglia G, Jeker H, Klein R, Ramseier U, Schmid J, Schreiber G, Seltenmeyer Y, Green JR. 2002. Highly potent geminal bisphosphonates. From pamidronate disodium (aredia) to zoledronic acid (zometa). J Med Chem 45: 3721–3738.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhu Z, Guan XU, Hou W, Yu H. 2009. Reciprocal roles between caffeine and estrogen on bone via differently regulating cAMP/PKA pathway: The possible mechanism for caffeine-induced osteoporosis in women and estrogen’s antagonistic effects. Med Hypotheses 73: 83–85.
   PubMed Web of Science ®Google Scholar